Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...

Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the ...

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...

Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it would be irreversibly tragic.

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring ...

NPR's Pien Huang speaks with pediatrician Alexandra Cvijanovich and Professor Jason L. Schwartz about trying to shore up trust about vaccines.

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

The author says the action creates mistrust of the committee’s vaccine recommendations and further increases patients’ and ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.